Pharma Pulse 3/31/25: Bridging the HCP-Patient Divide, Kennedy Proposes Massive Reorganization, Staff Cuts at HHS & more

The Evolution of Healthcare Communication: Bridging the HCP-Patient Divide

In a world riddled with misinformation online, trust-building between healthcare providers (HCPs) and their patients has become more important than ever. Being ill is stressful enough. Knowing who can deliver reliable, timely information at the point of diagnosis and beyond is essential. Studies have shown that high patient engagement serves for better health outcomes while simultaneously reducing medical costs. In light of technological advances such as global digital platforms and AI-assisted devices, the ability for HCPs to communicate with patients has become easier than ever.

Kennedy Proposes Massive Reorganization, Staff Cuts at HHS

The HHS secretary’s plans would create a new Administration for a Healthy America (AHA) subagency and slash the department’s workforce by 25%, including 3,500 full-time positions at the FDA.

Pharma Could Be Next Affected by Tariffs: Lombard Odier

Lombard Odier EMEA CIO Nannette Hechler-Fayd'herbe discusses the market impact of upcoming US tariffs on the auto sector. Speaking on Bloomberg Television, she says the impact of tariffs is "not fully priced by markets." Hechler-Fayd'herbe also adds that the pharmaceuticals sector may be the next to be affected by tariffs coming from President Donald Trump's administration.

Novotech Report Reveals Growth in siRNA Research: Over 150 Industry-Sponsored Clinical Trials Conducted from 2020 to 2024

Novotech has released its newest preclinical report exploring the evolving landscape of small interfering RNA (siRNA) therapeutics. The report provides insights for biotech and pharmaceutical companies leveraging RNA-based precision medicine to develop next-generation treatments for oncology, metabolic disorders, and rare genetic diseases.

Pharmaceutical Executive on LinkedIn

The editors of Pharmaceutical Executive® invite you to participate in the State of the Industry Survey, designed for leaders and decision-makers in the pharmaceutical and biotech industries.

This is an opportunity to share your perspective on the challenges and trends shaping the industry, from workforce issues and regulatory shifts to innovation strategies. Your input, along with insights from other executives and experts, will help create a comprehensive view of where the industry is headed.

Take the survey today!https://lnkd.in/eFKmeV9y

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs